GENERAL COMMENTARY article

Front. Pharmacol., 03 March 2015

Sec. Integrative and Regenerative Pharmacology

Volume 6 - 2015 | https://doi.org/10.3389/fphar.2015.00039

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells

  • 1. Stem Cells and Regenerative Medicine, Institute of Child Health, University College London London, UK

  • 2. Department of Obstetrics and Gynaecology, Chang Gung Memorial Hospital at Linkou Taoyuan, Taiwan

  • 3. Department of Obstetrics and Gynaecology, College of Medicine, Chang Gung University Taoyuan, Taiwan

  • 4. Prenatal Therapy, Institute for Women's Health, University College London London, UK

  • 5. Cellular Reprogramming and Perinatal Therapy, Institute for Women's Health, University College London London, UK

This article is a commentary on:

  1. In utero therapy for congenital disorders using amniotic fluid stem cells

    1. Read original article

A corrigendum on In utero therapy for congenital disorders using amniotic fluid stem cells by Ramachandra, D. L., Shaw, S. S. W., Shangaris, P., Loukogeorgakis, S., Guillot, P. V., De Coppi, P., and David, A. L. (2014). Front. Pharmacol. 5:270. doi: 10.3389/fphar.2014.00270

I am writing this manuscript to correct the second author information. My name is correctly spelt, S.W. Steven Shaw. But “S.W. Steven” is the first name, “Shaw” is the last name. My publications are always searched by “Shaw SW” in pubmed. However, in this article, my name is searched by “Shaw SS.”

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Summary

Keywords

amniotic fluid, stem cell, transplantation, prenatal, cell therapy

Citation

Ramachandra DL, Shaw S-WS, Shangaris P, Loukogeorgakis S, Guillot PV, De Coppi P and David AL (2015) Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells. Front. Pharmacol. 6:39. doi: 10.3389/fphar.2015.00039

Received

30 January 2015

Accepted

12 February 2015

Published

03 March 2015

Volume

6 - 2015

Edited and reviewed by

Graca Almeida-Porada, Institute for Regenerative Medicine, USA

Copyright

© 2015 Ramachandra, Shaw, Shangaris, Loukogeorgakis, Guillot, De Coppi and David.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence:

This article was submitted to Integrative and Regenerative Pharmacology, a section of the journal Frontiers in Pharmacology.

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Share on WeChat

Scan with WeChat to share this article

Article metrics